Drug Trials Snapshots: VOQUEZNA TRIPLE PAK, VOQUEZNA DUAL PAK
To treat Helicobacter pylori infection. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - November 27, 2023 Category: Drugs & Pharmacology Authors: FDA Source Type: news
Phathom Pharmaceuticals Announces FDA Approval of Reformulated Vonoprazan Tablets for Voquezna Triple Pak (vonoprazan, amoxicillin, clarithromycin) and Voquezna Dual Pak (vonoprazan, amoxicillin) for the Treatment of H. pylori Infection in Adults
FLORHAM PARK, N.J., Oct. 30, 2023 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal (GI) diseases, announced that the U.S.... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - October 31, 2023 Category: Drugs & Pharmacology Source Type: news
My son died of stomach cancer - I think he got it from a bug all travellers should know about
Zak Wilcox (pictured), was just 40 when he passed away in 2021. His mother believes he was infected with the bacteria Helicobacter pylori, which is known to increase the risk of stomach cancer. (Source: the Mail online | Health)
Source: the Mail online | Health - August 7, 2023 Category: Consumer Health News Source Type: news
The Helicobacter pylori CagA oncoprotein disrupts Wnt/PCP signaling and promotes hyperproliferation of pyloric gland base cells | Science Signaling
An H. pylori oncoprotein induces stomach epithelial hyperplasia by impairing planar cell polarity signaling. (Source: Signal Transduction Knowledge Environment)
Source: Signal Transduction Knowledge Environment - July 18, 2023 Category: Science Source Type: news
H pylori in RA Patients Who Stopped MTX for GI Intolerance H pylori in RA Patients Who Stopped MTX for GI Intolerance
Some rheumatoid arthritis patients need to discontinue methotrexate treatment due to gastrointestinal intolerance. Could H pylori infection be the cause of these adverse effects?Journal of Clinical Rheumatology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - June 14, 2023 Category: Consumer Health News Tags: Rheumatology Journal Article Source Type: news
H Pylori Eradication Therapy Curbs Risk for Stomach Cancer H Pylori Eradication Therapy Curbs Risk for Stomach Cancer
Results of a large retrospective study support the potential for substantial stomach cancer prevention in the United States through H pylori screening and treatment.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - May 5, 2023 Category: Cancer & Oncology Tags: Gastroenterology News Source Type: news
H. Pylori Infection Negatively Modifies Genetically Increased Risk for Gastric Cancer
THURSDAY, March 30, 2023 -- Helicobacter pylori (H. pylori) infection modifies the increased risk for gastric cancer associated with germline pathogenic variants in cancer-predisposing genes, according to a study published in the March 30 issue of... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - March 30, 2023 Category: Pharmaceuticals Source Type: news
A 'Double Whammy' for Gastric Cancer Risk
(MedPage Today) -- The combined effect of certain germline pathogenic variants and Helicobacter pylori infection were linked with large increases in gastric cancer risk, according to results from a Japanese study.
By age 85, the cumulative risk... (Source: MedPage Today Gastroenterology)
Source: MedPage Today Gastroenterology - March 29, 2023 Category: Gastroenterology Source Type: news
Gene Variants Plus H pylori Increase Risk of Gastric Cancer Gene Variants Plus H pylori Increase Risk of Gastric Cancer
Individuals with inherited pathogenic variants in genes associated with homologous recombination of DNA who also had H pylori infections had a 3-fold higher risk for gastric cancer vs infected noncarriers.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - March 29, 2023 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news
FDA Puts Hold on Esophagitis, H pylori Drug FDA Puts Hold on Esophagitis, H pylori Drug
The regulatory delays stem from the presence of trace levels of a nitrosamine impurity that were initially detected in launch materials for two vonoprazan products from Phathom Pharmaceuticals.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - February 15, 2023 Category: Drugs & Pharmacology Tags: Gastroenterology News Source Type: news
Carcinogens concepts receive input from NTP advisers
<img width="100" src="https://factor.niehs.nih.gov/sites/niehs-factor/files/styles/large/public/2016/5/science-highlights/ntp/thumb788986.jpg?itok=AmqZoaeL" /><br /><p>National Toxicology Program advisers gave scientific input on the bacteria Helicobacter pylori, and certain water disinfection by-products.</p>
(read more) (Source: Environmental Factor - NIEHS Newsletter)
Source: Environmental Factor - NIEHS Newsletter - February 3, 2023 Category: Environmental Health Source Type: news
Vonoprazan Triple Therapy Most Cost-Effective for H pylori: Study Vonoprazan Triple Therapy Most Cost-Effective for H pylori: Study
In the United States, vonoprazan triple therapy has significant health and economic benefits relative to other first-line H pylori eradication regimens, with rifabutin triple therapy a close second.Medscape Medical News (Source: Medscape Gastroenterology Headlines)
Source: Medscape Gastroenterology Headlines - December 30, 2022 Category: Gastroenterology Tags: Gastroenterology News Source Type: news
The Changes Made in the New Expert Consensus on H pylori The Changes Made in the New Expert Consensus on H pylori
With the last update published in 2017, current consensus, released in August 2022, covers most of the latest progress made in the management of the infection.Medscape Medical News (Source: Medscape Gastroenterology Headlines)
Source: Medscape Gastroenterology Headlines - November 15, 2022 Category: Gastroenterology Tags: Gastroenterology News Source Type: news
Eradicating H. pylori Cuts Aspirin-Related Peptic Ulcer Bleeding in the Short Term
MONDAY, Nov. 14, 2022 -- Eradication of Helicobacter pylori reduces the incidence of peptic ulcer bleeding in older adults receiving daily aspirin, but the advantage does not persist after the first 2.5 years of follow-up, according to a study... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - November 14, 2022 Category: General Medicine Source Type: news
What Are the Potential Benefits and Risks of Premasticated Foods?
Discussion
Premastication is the prechewing of foods or medicines by another person before feeding to an infant. It is also used to pretaste or temperature test foods. It was a common practice for millennia, especially before modern food technology, as a way to transition an infant from a solely liquid based diet to a mixed diet mainly of solid food. Rates of premastication vary, with less developed countries having an increased incidence/prevalence (up to 50%) but it is not uncommon in developed countries (in the US 14% is reported).
Saliva is also used to clean other people, treat cuts/itches or insect bites as well. Pla...
Source: PediatricEducation.org - November 14, 2022 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news
